PLoS ONE · 2013 · 122 citations · 20 references
Life SciencesImmunologyOncologyImmunotherapyTumor ImmunologyTumor ProgressionAntitumor T Cell ResponsesCancer ImmunotherapyHypoxia AdaptationImmunotherapy For Solid TumorsRegulatory T CellsT Cell BiologyCancer-associated ImmunosuppressionHypoxia Tolerance MechanismsHypoxic MicroenvironmentImmunotherapy For Gastric CancerLocal Tumor ProgressionMalignant Progression
Regulatory T cell (Treg)-mediated immunosuppression represents one of the crucial tumor immune evasion mechanisms and is a main obstacle for successful tumor immunotherapy. Hypoxia, a common feature of solid tumors, has been associated with potentiated immunosuppression, decreased therapeutic response, malignant progression and local invasion. Unfortunately, the link between hypoxia and Treg-mediated immune tolerance in gastric cancer remains poorly understood. In our study, Tregs and hypoxia inducible factor-1α were found to be positively correlated with each other and were increased with the tumor progression. A subsequent in vitro study indicated that supernatants derived from gastric cancer cells under hypoxic condition, could induce the expression of Foxp3 via TGF-β1. These findings confirmed the crucial role of Tregs as a therapeutic target in gastric cancer therapy and provided helpful thoughts for the design of immunotherapy for gastric cancer in the future.
20
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Eric V. Dang, Joseph Barbi, Huang‐Yu Yang et al. · Cell · 2011 · 1.6K citations · Full text
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Andrea Facciabene, Xiaohui Peng, Ian S. Hagemann et al. · Nature · 2011 · 1.4K citations
Medicine, Cancer Biology, Oncology +14
CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells in patients with gastrointestinal malignancies
Tetsuro Sasada, Motohide Kimura, Yuka Yoshida et al. · Cancer · 2003 · 475 citations
Life Sciences, Immunology, Oncology +17